Evidence map›Paper›PMID 23198122›Full record

ArticleJournal of global health2012

Balancing investments in existing and emerging approaches to address global health priorities.

Igor Rudan, Ana Marušić, Harry Campbell

Abstract read
In one paragraph

Article in Journal of global health, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Igor Rudan
Ana Marušić
Harry Campbell

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

One of the common themes in contemporary global health is finding an optimal balance between investments in existing and emerging approaches to fight global health priorities. Existing interventions have been proven to be effective, but they usually have limitations. Emerging interventions could potentially bring greater gains at a lower cost, but health gains are usually uncertain and take much more time to achieve. There are no simple solutions on how to balance funding support to these two competing approaches, but some components of successful strategies are becoming increasingly apparent. Transparency over the expected return on investment, style of investment and time horizon can assist rational investment decisions.

Identifiers

PMID23198122
PMCPMC3484755

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.